Combination of

Autor: Hayder M, Al-Kuraishy, Hany A, Al-Hussaniy, Ali I, Al-Gareeb, Walaa A, Negm, Aya H, El-Kadem, Gaber El-Saber, Batiha, Nermeen, N Welson, Gomaa, Mostafa-Hedeab, Ahmed H, Qasem, Carlos Adam, Conte-Junior
Rok vydání: 2022
Zdroj: Frontiers in pharmacology. 13
ISSN: 1663-9812
Popis: Doxorubicin (DOX) is an anticancer agent for treating solid and soft tissue malignancies. However, the clinical use of DOX is restricted by cumulative, dose-dependent cardiotoxicity. Therefore, the present study aimed to assess the cardioprotective effects of
Databáze: OpenAIRE